We examined the protein and fat nutritional status of 65 cystic fibrosis patients aged 4-26 y (x -± SD: 11.2 ± 5.6 y). Patients were treated with pancreatic enzyme extracts to improve nutrient absorption; in addition, most patients were supplemented with vitamins A and E. Results were compared with those in a control group of 39 subjects aged 5-29 y (x -: 14.3 ± 5.6 y) with no digestive diseases or nutritional deficiencies. Protein determination showed low albumin concentrations in 42% of the cystic fibrosis patients and decreased blood concentrations of retinol binding protein in 12% of the patients. Lipoprotein components were characterized by decreased cholesterol concentrations in 25% of the cystic fibrosis group. Also, mean concentrations of apolipoprotein A-I were significantly lower in the cystic fibrosis group than in control subjects. The results of fatty acid status, expressed in relative (%) and absolute (mg/L) values, showed concentrations of essential fatty acids, represented by linoleic and arachidonic acids, to be significantly decreased in cystic fibrosis patients; this decrease was markedly significant for fatty acid status expressed in absolute values, especially in the cholesteryl ester subfraction. Serum retinol and ␣-tocopherol concentrations were lowered by 8% and 46% in cystic fibrosis patients and control subjects, respectively: retinol, 1.80 ± 0.50 and 2.37 ± 0.60 mol/L, P < 0.001, and ␣-tocopherol, 18.1 ± 8.7 and 25.7 ± 5.0 mol/L, P < 0.001. In conclusion, despite regular treatment with pancreatic enzyme replacements, neither protein nor fat malnutrition in cystic fibrosis patients was completely corrected.
INTRODUCTION
Persons with cystic fibrosis (CF) are frequently affected by malnutrition, and nutritional problems can exist at an early age (1, 2) . CF is characterized by pancreatic insufficiency and pulmonary infections, which largely contribute to establishing low nutritional status and obvious oxidative stress (3) (4) (5) . Malabsorption due to pancreatic insufficiency leads to steatorrhea and azotorrhea, which cause the loss of energy and nutrients necessary for growth (6, 7) . Although there is a significant quantitative loss of unabsorbed protein (8, 9) , most of the energy lost in stools is in the form of fat. Therapeutic measures consisting mainly of pancreatic enzyme supplements are recommended to improve nutrient malabsorption in CF (8, 10, 11) . However, despite regular enzyme replacement, only partial correction of malnutrition has been reported (8, 10, 12) . The complete nutritional status of CF patients treated with pancreatic enzyme therapy has not been documented in detail.
The present study was performed to assess both protein and fat nutritional status in treated CF patients. We analyzed fatty acid status in two ways to estimate biochemical deficiencies in this important index of fat malnutrition. We believe that it is extremely important to measure the more representative biochemical indexes of malnutrition to estimate the effectiveness of the various treatments proposed to improve nutritional status.
SUBJECTS AND METHODS

Subjects
Sixty-five patients (38 males and 27 females) with CF from the Pediatric Center at Lyon-Sud Hospital were studied; the patients' ages ranged from 4 to 26 y (x -± SD: 11.2 ± 5.6 y). The diagnosis of CF was based on typical clinical symptoms and analysis of chloride and sodium in sweat. Most of the patients had a positive sputum culture for Pseudomonas aeruginosa (n = 35), Staphylococcus aureus (n = 40), and Haemophilus influenzae (n = 28).
All patients consumed an ordinary diet; the Pediatric Center of Lyon-Sud Hospital tends to recommend a high-energy diet [130−150% of recommended dietary allowances (13) ] for CF patients. Growth status was reported as percentage of ideal body weight. The median value for this anthropometric index was 92% and varied between 70% and 80% for 3 patients, between 80% and 90% for 19 patients, between 90% and 100% for 29 patients, and between 100% and 110% for 14 patients. Thus, 22 (34%) patients studied had an index < 90%, which is the criterion Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts for growth failure in the Pediatric Center of Lyon-Sud Hospital. The median Shwachman scores (14) 
Methods
Blood was drawn from fasting subjects and collected into serum preparation tubes. After centrifugation at 2500 ϫ g for 10 min at 4 °C, the serum was removed and analyzed immediately for protein concentration and lipoprotein constituents and frozen at Ϫ70°C for ≤ 2 wk for fatty acid and vitamin analysis. In the present study, serum for protein determin ation was not available for 31 CF patients.
Protein determination and fat nutritional status assays
Concentrations of serum albumin, prealbumin, and retinol binding protein (RBP) were determined by immunonephelometry with the Behring nephelometer system (16) .
Lipoprotein constituents
Cholesterol, triacylglycerol, and apolipoproteins A-I and B (apo A-I and B) were measured in a Cobas instrument (Roche, Somerville, NJ) with in vitro diagnostic kits (cholesterol: Biomérieux, Marcy-L'Etoile, France; triacylglycerol: MerckBiotrol, Nogent-Sur-Marne, France; and apo A-I and B: Roche).
Fatty acids
Total serum lipids were extracted in chloroform:methanol (1:1, by vol). We first separated phospholipids and cholesteryl esters (CEs) by thin-layer chromatography; we next methylated these two lipid fractions separately and analyzed the fatty acid methyl esters by capillary gas−liquid chromatography. The fatty acid compositions of phospholipids and CEs were expressed two ways. First, for the entire study population, we determined the area of each of the fatty acid peaks on the chromatogram and calculated the percentage of each fatty acid in comparison with the total. Second, for a group of patients (n = 13) who had values for lipid status and percentage fatty acids similar to those of the entire CF group, we determined the concentration of each fatty acid in phospholipid and CE, expressed in absolute values (mg/L), by adding a known quantity of diheptadecanoyl phosphatidylcholine and cholesteryl heptadecanoate to the serum as internal standards (17, 18) ; the retention time was similar (12.5 ± 0.5 min) for both standards.
Fat-soluble vitamins
Vitamins A (retinol) and E (␣-tocopherol) were measured simultaneously by HPLC procedures according to the method of Catignani and Bieri (19) .
Statistical analysis
Results were analyzed for significance by using Student's t test and, if appropriate, the Mann-Whitney U test, with the limit of significance at P < 0.05. All results are expressed as means ± SDs. Simple regression analysis was used for statistical estimation of correlation coefficients between the different indexes studied.
RESULTS
Serum protein status of CF patients
Mean concentrations of albumin and RBP were significantly lower in CF patients than in control subjects ( Table 1) . Fortytwo percent of CF patients had albumin concentrations > 2 SDs below the mean for the control group and 12% had RBP values > 2 SDs below the mean for the control group. Serum prealbumin concentrations did not differ significantly between the control subjects and the CF patients. Table 2 , CF patients had significantly lower serum concentrations of cholesterol and apo A-I than did control subjects. The total serum cholesterol concentration in 16 of the CF patients (25%) was > 2 SDs below the mean control value. There was no significant difference in serum triacylglycerol or apo B concentrations between the two groups. A positive correlation was found between cholesterol and apo A-I and between cholesterol and apo B (r = 0.50, P < 0.001) for both the control group and the CF patients.
Lipoprotein constituents
As indicated in
Fatty acid pattern of the total phospholipid and CE fractions in serum
The fatty acid compositions of the phospholipid and CE fractions (Tables 3 and 4) were abnormal in CF patients compared with control subjects. The distribution of fatty acids as a percentage of the total (Table 3) showed a significant decrease in mean percentages of stearic (18:0), linoleic (18:2nϪ6), arachidonic (20:4nϪ6), and docosahexaenoic (22:6nϪ3) acids in phospholipid. For the CE fraction, no differences were observed in 18:0 or 20:4nϪ6 between CF patients and control subjects; only 18:2nϪ6 was significantly decreased in the CF population. On the other hand, the mean percentages of palmitic (16:0), palmitoleic (16:1nϪ7), oleic (18:1nϪ9), eicosatrienoic (20:3nϪ9), and dihomo-␥-linoleic (20:3nϪ6) acids were significantly higher 
CF patients
Control subjects (n = 34)
in CF patients than in control subjects in both the phospholipid and CE fractions. Of all fatty acids analyzed, 16:1nϪ7 differed the most between control subjects and CF patients in both lipid fractions studied, being higher in CF patients. 20:3nϪ9 was not detectable in the CE fraction in the control group but was present in CF patients. There were no significant differences in mean percentages of ␣-linolenic (18:3nϪ3) acid for either serum fraction between the two groups. Also, percentages of docosatetraenoic (22:4nϪ6) and docosapentaenoic (22:5nϪ3) acids in the phospholipid fraction did not differ between CF patients and control subjects. When fatty acids were expressed as absolute serum concentrations in the phospholipid and CE fractions (Table 4) , there was a more pronounced decrease in concentrations of 18:0, 18:2nϪ6, and 20:4nϪ6 in CF patients than seen when fatty acids were expressed as percentages. In contrast with results when fatty acids were expressed as percentages, mean concentrations of 16:0 in the phospholipid and CE fractions were significantly lower in CF patients than in control subjects; concentrations of 18:1nϪ9 were significantly lower in CF patients in the CE fraction but not significantly different between groups in the phospholipid fraction. Only the absolute concentration of 16:1nϪ7 in the phospholipid and CE fractions was significantly higher in CF patients than in control subjects. Concentrations of 18:3nϪ3 in both fractions was not significantly different between CF patients and control subjects.
As a further measure of fatty acid status, we calculated the sum and ratios of some fatty acids used as biomarkers for estimating deficiencies in essential fatty acids (EFAs) and defects in metabolism of EFAs. The results (Table 3) showed significantly higher amounts of saturated and monounsaturated fatty acids, significantly lower amounts of total polyunsaturated fatty acids, and a significantly lower ratio of polyunsaturated to saturated fatty acids in CF patients than in control subjects for both phospholipid and CE fractions. Total nϪ3 metabolites in the phospholipid fraction were lower in CF patients but were not different from control subjects in the CE subfraction. In addition, total nϪ6 metabolites in both fractions were decreased in CF patients compared with control subjects. Total nϪ9 metabolites and the ratio of total nϪ9 to total nϪ6 fatty acids were higher in CF patients than in the control group. The calculated ratio of 20:3nϪ9 to 20:4nϪ6 was significantly higher in both the phospholipid and CE fractions in CF patients than in control subjects. Nevertheless, none of the CF patients had a ratio > 0.4, which is the critical value used in diagnosing EFA deficiency (20) . 2 Significantly different from control subjects, P < 0.001. 
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Significantly different from control subjects: 2 P < 0.001, 3 P < 0.01, 4 P < 0.05.
Concentrations of fat-soluble vitamins
Serum retinol and ␣-tocopherol concentrations were significantly lower in CF patients than in control subjects ( Table 5) . Five patients (8%) had retinol concentrations > 2 SDs below the mean control value; none of these patients, however, had retinol status lower than the reported critical threshold value of retinol deficiency (0.35 mol/L). We found a good correlation between serum retinol concentration and concentrations of both RBP and prealbumin (r = 0.76, P < 0.001) for both control subjects and CF patients. The molar ratio of retinol to RBP, as a measure of RBP saturation, was significantly lower in CF patients than in control subjects (1.43 ± 0.17 compared with 1.27 ± 0.16, P = 0.001).
Thirty patients (46%) had ␣-tocopherol concentrations > 2 SDs below the mean control value; 12 patients (18%) had values < 9.3 mol/L, which is the critical value for ␣-tocopherol deficiency reported in the literature. A simple linear regression showed a significant positive correlation between ␣-tocopherol and cholesterol in both the control subjects (r = 0.73, P < 0.001) and the CF patients (r = 0.49, P < 0.001). The ratio of ␣-tocopherol to cholesterol in CF patients was not different from that in control subjects. Serum concentrations of ␣-tocopherol and cholesterol were both diminished in CF patients; therefore, the calculated ratio of ␣-tocopherol to cholesterol in CF patients was not significantly different from that in control subjects.
DISCUSSION
The results of the present study showed that protein and fat nutritional status was disturbed in CF patients. Despite regular pancreatic enzyme therapy, impaired nutritional status persisted in several patients, as confirmed by biochemical evidence of malnutrition. This impaired status could not have been due to inactivation of the enzymes in the stomach because the pancreatic enzyme supplements are in the form of enteric-coated microspheres that prevent enzyme degradation (10, 12, 21) . The partial response to pancreatic enzyme therapy could, however, have been caused by inactivation of these enzymes in the small intestine as result of a low duodenal pH caused by pancreatic impairment of bicarbonate secretion. Bouquet et al (10) showed that even with pancreatic enzyme therapy, complete correction of fat absorption is not attained. Fernandes et al (22) reported that administration of pancreatic extracts considerably improves fat absorption but does not normalize it, even when the dosage is increased.
The main enzymes included in pancreatic extracts are lipase, amylase, and trypsin (11, 12) . However, CF is known to be associated with a deficiency of bile salts, which results in reduced emulsifying capacity and decreased enzyme activation (23, 24) . In the present study, the enzyme replacement was not administered with bile salts. Moreover, malabsorption in CF can be related to liver malfunction and to disorders in the resorptive processes of the intestinal mucosa in addition to pancreatic insufficiency (25, 26) . On the other hand, many authors have found a correlation between a decline in lung function, the presence of chest infection, and a diminished nutritional status, because appetite usually decreases during acute episodes of pulmonary infection (4, 27) .
In the present study we measured concentrations of serum albumin, prealbumin, and RBP to estimate protein malnutrition. Prealbumin and RBP are sensitive indicators of protein metabolism; these proteins serve as transport proteins to convey vitamin A in the form of retinol to peripheral tissues (28) . Albumin is a protein that turns over slowly. Littlewood and MacDonald (29) reported that there is little clinical or biochemical evidence of protein deficiency in CF patients treated with modern pancreatic extracts. Fecal nitrogen excretion is reduced more effectively than fat losses by the administration of pancreatic extracts (30) . However, in the present study, albumin concentrations were below normal in 42% of the CF patients. Prealbumin concentrations were not altered but RBP was decreased in 12% of CF patients. Hendricks et al (31) reported that serum albumin concentrations decrease in response to infections or other types of stress. Oxidative stress is usually described in CF as a consequence of inflammatory and infectious processes (5, 32) .
As was shown previously, malabsorption may have important influences on lipid nutritional status. Vaughan et al (33) showed that cholesterol concentrations in blood were decreased by 34% in CF patients compared with control subjects and were correlated with gastrointestinal scores, which were graded from 0 to 4 in order of increasing severity of gastrointestinal problems (including symptoms of malabsorption). In our study, 25% of the CF population had low concentrations of blood cholesterol. Marked fecal losses of bile acids occur in CF patients and vary with the degree of pancreatic insufficiency (23, 24, 34) . Low cholesterol concentrations in blood can partially be due to a reduction in the enterohepatic circulation of bile acids (35) and also to a possible defect in biosynthesis.
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[We showed previously that cholesterol deficiencies exist during the first days of life (unpublished observations, 1986).] Levy et al (35) showed that hypocholesterolemia in CF was associated with a decrease in both HDL and LDL cholesterol. In our study, mean concentrations of triacylglycerol in CF patients treated with pancreatic lipase were not different from those in control subjects. This result agrees with the findings of James et al (36) , whereas Vaughan et al (33) and Levy et al (35) showed an increase in triacylglycerol concentrations in CF patients. Also, these investigators observed higher concentrations of VLDL and lower concentrations of LDL and HDL in EFA-deficient CF patients than in EFA-sufficient patients. Levy et al (35) related the impairments in lipoprotein and triacylglycerol concentrations in CF patients to EFA deficiencies, which are dependent on the severity of the malabsorption.
On the whole, the fatty acid status reported in our study agrees with reports from several studies of blood fatty acid profiles in CF, in which abnormal fatty acid status was found in CF patients who were treated frequently with pancreatic extracts (37) (38) (39) (40) . Our results showed a more marked decrease in 18:2nϪ6 and 20:4nϪ6 when these fatty acids were assessed as absolute values (mg/L) rather than as percentages. The largest fatty acid impairments were observed in the CE fraction, as indicated previously by others (41) . To our knowledge, fatty acid status in CF patients has not been expressed previously in absolute values: as far as we know, all previous reports expressed fatty acid status in percentages of total fatty acids. Our results showed greater decreases in EFA concentrations in CF patients when fatty acids were expressed in absolute concentrations than when they were expressed as percentages, especially in the CE subfraction. Also, 16:0 expressed as an absolute value was lower in CF patients than in control subjects, whereas it was higher when expressed as a percentage, as has been reported previously (38, 39) . The absolute assessment of fatty acid concentrations in CF gives a more biologically significant representation of fatty acid profiles than relative assessment and indicates biochemical deficiencies of some fatty acids (20:4nϪ6 and 16:0) that are not noticeable with relative assessment.
All reports on fatty acid profiles in CF confirm the existence of an EFA deficiency, especially of 18:2nϪ6. However, controversial discussions have taken place about the origin of the EFA deficiency in CF. Because CF is associated with various complications, multifactorial causes of the EFA deficiency have been suggested. A large group of investigators relate the EFA deficiency in CF to malabsorption of ingested fat secondary to pancreatic insufficiency (41, 42) . Other groups suggest that the deficiency results from a metabolic defect in fatty acid metabolism brought about by altered activity of desaturases (43) . A higher turnover of certain EFAs in CF (especially 20:4nϪ6), marked by deterioration of pulmonary function, has also been suggested (37, 44) . Malnutrition resulting from energy intake below requirements is related to EFA deficiency in CF (45); furthermore, a lipid peroxidation process has been suggested to explain the EFA deficiency (46) .
EFA deficiency appears to play a major role in the pathophysiology of CF, and has been used as model system for CF in certain animals. EFA-deficient rabbits were shown to have impaired alveolar macrophage function, similar to that found in CF patients (47) . EFA-deficient chickens develop chronic respiratory disease through an alteration of the composition and function of surfactant (44) . In the present study, some CF patients developed respiratory infections and had positive sputum cultures for P. aeruginosa, S. aureus, and H. influenzae, the same observation made by Lloyd-Still et al (40) .
Our results showed significant decreases in concentrations of retinol and ␣-tocopherol in CF patients despite regular supplementation of most of the patients. Deficiencies of retinol and ␣-tocopherol in CF are well-known consequences of fat malabsorption (48−52) . Retinol deficiencies are also explained by a defect in mobilization and transport of retinol from liver into plasma and by depleted tissue concentrations (49, 50, 53) . Smith et al (53) showed a positive correlation between the decrease in retinol concentration in supplemented CF patients and the decrease in plasma concentrations of the transport proteins represented by RBP and prealbumin. This was confirmed in the present study: blood retinol concentrations correlated positively with both serum RBP and prealbumin concentrations.
Several of the CF patients in the present study were supplemented with vitamins A and E. In our results, ␣-tocopherol serum concentrations were more impaired than retinol concentrations. It seems that CF patients respond well to vitamin A supplementation. On the other hand, ␣-tocopherol concentrations were lower in 30 CF patients (46%) than in control subjects and marked biochemical deficiency occurred, despite regular supplementation of 40 CF patients with all-rac-␣-tocopheryl acetate in doses from 1.75 to 30.7 mg ؒ kg Ϫ1 ؒ d Ϫ1 . Among the 30 ␣-tocopherol−deficient CF patients, 13 (43%) were supplemented and 17 (57%) were unsupplemented with vitamin E. Our results agree with those of Winklhofer-Roob et al (54) , who reported that Ϸ17−45% of supplemented patients and 50−87% of unsupplemented patients had ␣-tocopherol concentrations lower than normal values unless they received 400 IU vitamin E/d, with no differences between the RRR-and all-rac-forms (55).
In conclusion, despite regular treatment with pancreatic extracts, malnutrition persisted in CF patients. Albumin, one of the best indexes of protein status and a good marker of metabolic stress, was lower in 42% of CF patients than in control subjects. Fatty acid status was disturbed and mean EFA concentrations were significantly below normal. Therapy with vitamins A and E did not completely normalize blood concentrations, especially of vitamin E. Our data confirm that the biochemical malnutrition in CF patients results not only from malabsorption but also from causes such as repeated and chronic chest infection, which induces increased metabolic rates and energy requirements. Further investigations should establish the nutritional treatment 
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Significantly different from control subjects, 2 P < 0.001, 3 P < 0.01.
